Skye Bioscience Inc at Benzinga Global Small Cap Conference (Virtual) Transcript
Punit Dhillon, he is the CEO and Chair of Skye Bioscience. I see him here. There he is.
Sir, good morning. How are we doing today?
Hey, good morning. Such a nice day to be on the show again. Thanks.
Yes, it's great to have you back. Guys, I see Punit's slides there. Let's get them up on the screen. We're good to go. The floor is yours, sir.
Awesome. Well, pleasure being on the Bezinga show and thanks again for inviting us. This is incredible in terms of the Benzinga platform and we love getting the story out.
Skye Biosciences is a pharmaceutical cannabinoid company. Before I begin, I'm going to just remind everyone to please review the risk factors associated with some of the forward-looking statements I'm going to be making. Those can be found in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
